Self-Assembling Peptide Hydrogel Shows Moderate Bone Repair But BMP-2 Combination Performs Best | Research

The takeaway

A self-assembling peptide hydrogel showed moderate bone formation in rat femur defects, but BMP-2 combined with bone chips produced the best bone regeneration, highlighting the need for osteoinductive factors alongside peptide scaffolds.

BV/TV 0.78 with BMP-2 + bone chips
More than double the bone volume achieved by self-assembling peptide hydrogel alone (0.34) at 56 weeks in rat femoral defects

What the researchers found

Self-assembling peptide hydrogel (0.8%) produced a bone-volume-to-total-volume (BV/TV) ratio of 0.34 ± 0.09 at 56 weeks, which was not significantly higher than the empty control cage. BMP-2 (50 ng/μL) with bone chips achieved the highest BV/TV ratio of 0.78 ± 0.05, significantly exceeding bone chips alone (p<0.01) and peptide hydrogel with bone chips (p<0.05). The results indicate that peptide hydrogels benefit from combination with osteoinductive factors like BMP-2.

Why it matters

Large bone defects from trauma, tumor removal, or infection remain a major surgical challenge. Self-assembling peptide hydrogels are attractive because they're injectable and can be used in minimally invasive procedures. Understanding that they need to be combined with growth factors like BMP-2 guides their clinical development toward combination products rather than standalone use.

How the study worked

Ten-week-old female Wistar rats received 5-mm femoral mid-shaft defects stabilized with external fixators and filled with PEEK cages containing various materials. Two experiments were performed: materials alone, then materials combined with bone chips. Bone formation was assessed at 56 weeks by radiographic and histological analysis with BV/TV ratio quantification.

What this study cannot tell us

This is a rat model, and bone healing differs between rats and humans. The 56-week timeline is exceptionally long for a rat study but still represents preclinical data. The peptide hydrogel concentration (0.8%) and BMP-2 dose (50 ng/μL) represent specific formulations that may not be optimal. Small group sizes typical of these surgical models limit statistical power.

How to read the evidence

This is a preclinical animal study using a well-established critical-sized defect model with quantitative outcome measures. While methodologically sound for its level, rat bone healing studies have limited direct translatability to human orthopedic applications.

When this study was published

Published in 2025, this study reflects ongoing efforts to optimize peptide-based biomaterials for orthopedic applications.

The bigger picture

Self-assembling peptide hydrogels represent an emerging class of biomaterials in orthopedic regenerative medicine. While they provide excellent scaffolding properties (injectability, biocompatibility), this study confirms what the field has increasingly recognized — that scaffolds alone are rarely sufficient for large defect repair. The future likely lies in peptide scaffold-growth factor combinations that provide both structural support and biological signaling.

Questions still open

Could loading BMP-2 directly into the self-assembling peptide hydrogel combine the benefits of both in a single injectable product?
Would higher concentrations of peptide hydrogel or modified peptide sequences improve bone formation without needing BMP-2?
How would this peptide hydrogel perform in human spinal fusion or fracture non-union applications?

Common questions

What is a self-assembling peptide hydrogel?

It's a gel made from short peptide chains that spontaneously organize themselves into a 3D network when placed in the body. This creates a soft scaffold that cells can grow into. The advantage is that it can be injected as a liquid and forms its structure in place, potentially allowing minimally invasive bone repair procedures.

Why didn't the peptide hydrogel work well enough on its own?

While the hydrogel provided a good physical scaffold for cells to grow on, it lacked biological signals to actively stimulate bone formation. BMP-2, a bone growth protein, provides those signals. The study suggests the best approach combines a peptide scaffold (for structure) with a growth factor (for biological stimulation).

Read the original research

Comparative analysis of bone regeneration in critical-sized defects using self-assembling peptide hydrogel-178, bone morphogenetic protein-2, and calcium phosphate scaffolds in a rat femur model.

Nagoya journal of medical science, 87(3), 421-430

View on PubMed ↗Publisher’s paper ↗

Citation

Yamauchi, Ippei; Nakashima, Hiroaki; Ito, Sadayuki; Segi, Naoki; Ouchida, Jun; Morita, Yoshinori; Ode, Yukihito; Nagatani, Yasuhiro; Okada, Yuya; Ando, Kei; Imagama, Shiro. (2025). Comparative analysis of bone regeneration in critical-sized defects using self-assembling peptide hydrogel-178, bone morphogenetic protein-2, and calcium phosphate scaffolds in a rat femur model.. Nagoya journal of medical science, 87(3), 421-430. https://doi.org/10.18999/nagjms.87.3.421